FR2276032A1 - Nouvelles cetones aromatiques douees d'activites cardiovasculaires - Google Patents

Nouvelles cetones aromatiques douees d'activites cardiovasculaires

Info

Publication number
FR2276032A1
FR2276032A1 FR7519386A FR7519386A FR2276032A1 FR 2276032 A1 FR2276032 A1 FR 2276032A1 FR 7519386 A FR7519386 A FR 7519386A FR 7519386 A FR7519386 A FR 7519386A FR 2276032 A1 FR2276032 A1 FR 2276032A1
Authority
FR
France
Prior art keywords
enhanced
aromatic ketones
new aromatic
cardiovascular activities
cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7519386A
Other languages
English (en)
Other versions
FR2276032B1 (fr
Inventor
Henri Demarne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CM Industries SA
Original Assignee
CM Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CM Industries SA filed Critical CM Industries SA
Publication of FR2276032A1 publication Critical patent/FR2276032A1/fr
Application granted granted Critical
Publication of FR2276032B1 publication Critical patent/FR2276032B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7519386A 1974-06-28 1975-06-20 Nouvelles cetones aromatiques douees d'activites cardiovasculaires Granted FR2276032A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28925/74A GB1501632A (en) 1974-06-28 1974-06-28 Aromatic ketones having cardiovascular activity

Publications (2)

Publication Number Publication Date
FR2276032A1 true FR2276032A1 (fr) 1976-01-23
FR2276032B1 FR2276032B1 (fr) 1979-08-10

Family

ID=10283421

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7519386A Granted FR2276032A1 (fr) 1974-06-28 1975-06-20 Nouvelles cetones aromatiques douees d'activites cardiovasculaires

Country Status (17)

Country Link
US (2) US4252825A (fr)
JP (2) JPS5826743B2 (fr)
AR (1) AR205388A1 (fr)
AT (1) AT343098B (fr)
BE (1) BE830766A (fr)
CA (1) CA1052820A (fr)
CS (1) CS197248B2 (fr)
DE (1) DE2528147A1 (fr)
DK (1) DK143555C (fr)
ES (1) ES438931A1 (fr)
FR (1) FR2276032A1 (fr)
GB (1) GB1501632A (fr)
IE (1) IE41386B1 (fr)
NL (1) NL7507703A (fr)
SE (2) SE416546B (fr)
YU (1) YU165775A (fr)
ZA (1) ZA754141B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
JPH0516363Y2 (fr) * 1986-08-01 1993-04-28
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
WO2004106299A2 (fr) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Derives pyrroliques substitues
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2014170786A1 (fr) 2013-04-17 2014-10-23 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
CN113574055A (zh) 2019-01-18 2021-10-29 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (fr) * 1962-12-11
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
DE1493454C3 (de) * 1963-08-26 1980-04-30 C.H. Boehringer Sohn, 6507 Ingelheim 1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
GB1231783A (en) * 1967-05-16 1971-05-12 May & Baker Ltd Benzene derivatives
JPS512115B2 (fr) * 1971-09-28 1976-01-23
JPS4911847A (fr) * 1972-05-20 1974-02-01
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity

Also Published As

Publication number Publication date
AU8256675A (en) 1977-01-06
ATA497275A (de) 1977-09-15
DK292475A (da) 1975-12-29
AR205388A1 (es) 1976-04-30
SE416546B (sv) 1981-01-19
BE830766A (fr) 1975-12-29
AT343098B (de) 1978-05-10
CA1052820A (fr) 1979-04-17
CS197248B2 (en) 1980-04-30
SE7812646L (sv) 1978-12-08
SE7507359L (sv) 1975-12-29
DK143555B (da) 1981-09-07
NL7507703A (nl) 1975-12-30
ZA754141B (en) 1976-06-30
IE41386B1 (en) 1979-12-19
JPS5123233A (en) 1976-02-24
IE41386L (en) 1975-12-28
DK143555C (da) 1982-02-01
SE417087B (sv) 1981-02-23
US4252825A (en) 1981-02-24
YU165775A (en) 1982-02-28
ES438931A1 (es) 1977-05-16
US4302601A (en) 1981-11-24
GB1501632A (en) 1978-02-22
FR2276032B1 (fr) 1979-08-10
DE2528147A1 (de) 1976-01-15
JPS5929574B2 (ja) 1984-07-21
JPS58140050A (ja) 1983-08-19
JPS5826743B2 (ja) 1983-06-04

Similar Documents

Publication Publication Date Title
BE851505A (fr) Nouvelles carbonylpiperazinylquinazolines
FR2276032A1 (fr) Nouvelles cetones aromatiques douees d'activites cardiovasculaires
SE7500966L (sv) Koboltbaserad legering
FR2283545A1 (fr) Panneau d'affichage
AT333520B (de) Abriebfeste und korrosionsfeste legierung
BE853779A (fr) Nouvelles isothiazolopyridines
BE827507A (fr) Panneau d'affichage
SE7607683L (sv) 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso/b//d/-pyraner och-pyranoner
JPS5123272A (ja) Karubamoiruarukokishi 3*44 jihidoroisokarubosuchirirujudotaino seizoho
FI773221A (fi) Tymosin alfa 1
FR2306310A2 (fr) Element d'espacement
BE858309A (fr) Nouvelles aryl-alkylamines
FR2296626A1 (fr) 2,6-methano-3-benzazocines
JPS5136506A (ja) Denkishimakisengajujoshitesochakusarenai 3 so no chokuryudendoki
JPS511481A (ja) Karubokishiarukokishi 3*44 jihidorokarubosuchirirujudotaino seizoho
JPS5120800A (ja) Ketsushoseirinsansuisochitan 1*2 suiwabutsuno seizohoho
JPS5136498A (ja) 2*2**anhidoroarabinofuranoshirurashirujudotainoseiho
AT352412B (de) Korrosionsbestaendige chromnickel legierung
FI55035C (fi) Foerfarande foer framstaellning av effektivt resorberbar hjaertaktiv 3beta-(4'-oxo-alfa-l-ramnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid
FR2290190A1 (fr) 4,5-secosteroides
JPS5163987A (ja) Roishinaminopepuchidaaze 2 no seizoho
IT1029956B (it) 3 benzofurilcumarine
IT1047675B (it) 2 triolorometil 1.3.4.tiadiazolo
DD133689A1 (de) Korrosionshemmende komposition
JPS511480A (ja) Etokishikaruboniruarukokishi 3*44 jihidorokarubosuchirirujudotaino seizoho

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse